📊 Score Breakdown
Offering Ability
90
Cash Runway
95
Float Risk
15
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
52%
💰 Capital Raise
75%
• Critical: only 1.3 months cash remaining
• Active shelf registration ($200M, 3071% of market cap)
📉 Score Deterioration
50%
• Score rose 53 points recently (worsening)
• Score in HIGH risk zone (73/100)
💹 Market Data
Market Cap$6.51M
Shares Outstanding1.66M
Float1.38M
Cash$1.96M
Debt$6.09M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 3.4% shares (2025Q4 vs prior)
42 institutional holders · 13.44M shares
#1
ACORN CAPITAL ADVISORS, LLC
4.84M shares
#2
VANGUARD GROUP INC
1.95M shares
#3
MARSHALL WACE, LLP
891.6K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest162.6K
Days to Cover5.5
% of Float11.8%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
8-K
8K EVENT
Mar 23, 2026
424B2
ATM
Mar 20, 2026
424B2
ATM
Mar 13, 2026
4
INSIDER TRANSACTION
Mar 12, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for BCAB
📊 BCAB FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 BCAB Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.